37
EP Life Sciences L.P. updates its Form D — $507.8M sold
Fund raise update · Other fund · Open-ended · Offering Indefinite · Sold $507.8M · NEW YORK, NY · filed 2026-05-14
3(c)(7) — qualified purchasers
37
EP Life Sciences L.P. updates its Form D — $471.1M sold
Fund raise update · Other fund · Open-ended · NEW YORK, NY · Form D/A filed 2025-05-14 · all Ep Life Sciences vehicles
$100M+ sold3(c)(7) — qualified purchasers
Why now — by persona
Relevant to: Fund audit & tax, Fund administrator. Lead card pending.
People on the filing
| Patrick JC Shaw | Investment Committee Member of the General Partner of the General Partner. |
| Sanford B. Ehrenkranz | Investment Committee Member of the General Partner of the General Partner. |
| Joel S. Ehrenkranz | Investment Committee Member of the General Partner of the General Partner. |
| Andrew B Sommers | Investment Committee Member of the General Partner of the General Partner. |
| Kabir JC Kapoor | Investment Committee Member of the General Partner of the General Partner. |
| John B Ehrenkranz | Investment Committee Member of the General Partner of the General Partner. |
Signed by Michael Sancilio, Authorized Signatory.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.